Quick Answer
Maze Therapeutics, Inc. reported Shares Outstanding of 49.34 million shares for fiscal year 2025.
Maze Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 49.34M | +1916.3% |
| 2024 | 2.45M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 48.08M | — | +9.6% |
| June 30, 2025 | 43.85M | — | +0.1% |
| March 31, 2025 | 43.80M | — | +1689.9% |
| December 31, 2024 | 2.45M | — | — |
- Maze Therapeutics, Inc. showed an increase of +1916.3% in Shares Outstanding compared to the prior fiscal year.
- Over the 2024–2025 period, Maze Therapeutics, Inc.’s shares outstanding has grown by 1916.3% (from 2.45 million shares to 49.34 million shares).
- The most recent figure is from Maze Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: